We have worked with HTA Ltd. throughout the years, and we are extremely happy with the analyses they have done on some of our most important products. Their omprehensive HTA reports and concise pharmacoeconomic analyses are characterized by consistent excellence. HTA Ltd. develops reports following the highest standards in terms of both, quality, and professionalism. Janssen Bulgaria strongly recommends HTA Ltd. as a reliable provider of health technology assessment services always on time, within budget.

When it comes to the Bulgarian market, we've already had several market accesses projects in the recent years and in all of them we've chosen HTA Ltd. to work with. HTA Ltd. have been a reliable partner in provinding us with a precisely written and detailed HTA dossiers, delivered timely and in short terms. (...) Swixx BioPharma Bulgaria strongly recommends HTA Ltd. services as a detailed, accurate, and within the agreement time framework.

As a big pharmaceutical company, we strongly rely on the precise analysis of our products. When it comes to the Bulgarian market, we rely on HTA Ltd. for providing us with reliable, well-organized and detailed reports. That is why we would strongly recommend them to any potential clients in Bulgaria. The professional level is higher than expected and satisfies Novartis’ standards and requirements.”

We strongly recommend Health Technology Assessment Ltd. (HTA Ltd.) Bulgaria as a reliable provider of health technology assessment services, on time, within budget. Through its work in partnership with HTA Ltd., Pfizer aims to ensure reliable and comprehensive data and professional analysis on its products.”

HTA Ltd. is a team of professionals with an extensive network of prominent experts, and their job is impressive. HTA Ltd. is a trusted partner and meets Sanofi’s high standards and requirements.

We believe that the health technology assessment of products must be executed by specialists and experts who are familiar with the Bulgarian and the international regulations and market environment, with the necessary qualification for fulfilling such tasks, and who have the skills to analyze all information in a professional way and within the agreed time framework. For that reason Eli Lilly recommends the services of HTA Ltd. for providing HTA support in preparation of analyses of medicinal products.

Positive Health Technology Assessment is a key step in successful market entry for medicinal products. Conducting qualitative and precise pharmacoeconomic analysis could sometimes be very challenging, especially in short terms. We trust HTA Ltd. to produce the pharmacoeconomic analysis of AbbVie’s products because we receive professional service within the specified term. We strongly recommend HTA Ltd. as a reliable partner with high standards of work.

We rely on HTA Ltd., which managed to provide a precisely written and detailed HTA report, for a less than a month, which was evaluated with a positive recommendation by the Health Technology Assessment Commission, three months later. After our work with HTA Ltd. we would strongly recommend their services as detailed, accurate, and within the agreed time framework.

Strategic launch plans of Medis Pharma Bulgaria have been greatly enhanced by our collaboration with HTA Ltd. HTA Ltd. delivered timely, evidence- based reimbursement dossier for submission of one of our products, which is the first in its class for the symptomatic treatment of blepharospasm, cervical dystonia of a predominantly rotational form (spasmodic torticollis) and spasticity of the upper limb. With their scientific and analytical expertise, we found the HTA Ltd. team to be dedicated and insightful, having met the expectations of this demanding project.

Our company strives to qeliver the best medical solutions for patients in need, including patients with mental health issues. HTA Ltd. helps us achieve our mission in Bulgaria through its team of professionals who rovide unmatched clinical and pharmacoeconomic expertise when assessing our pharmaceutical products. Working with HTA Ltd. is both very enjoyable and unquestionably fruitful.

Our varied portfolio often requires an individualized approach. HTA Ltd. offers tailored and innovative solutions distinguished by superb quality. Their professional team always delivers without ever sacrificing excellence and does so in a timely fashion, having never missed a deadline. We strongly recommend working with HTA Ltd.

Working with HTA Ltd. has been an incredibly productive endeavour. HTA Ltd. offers interactive project developments, customized to our needs, to assure the highest quality of health technology assessments of our medical devices. Their analyses feature thorough scientific, clinical, ethical, and economic solutions that shape the developing medical landscape of Bulgaria.

HTA Ltd. (Health Technology Assessment) was founded in 2015 as a consulting company and during its presence at Bulgarian market so far, they added a significant value to healthcare sector trying to transform it, providing health policy advisory, healthcare management and market access services. (…) Moreover, the presence of HTA Ltd. has helped the institution of high professional standards in the Bulgarian market which undoubtedly is a significant achievement and credential to their commitment to business ethics and work ethic live up to the highest of standards.

We worked with HTA Ltd to prepare an HTA submission dossier for the reimbursement of a novel oncology product in Bulgaria, using the PRMA Navigator® application, on behalf of a pharmaceutical company. HTA Ltd offered expert local insights throughout the process and worked efficiently to develop the dossier against a tight timeline. The communication from the team at HTA Ltd was excellent throughout the process, and we look forward to continuing this partnership.

We have collaborated with HTA Ltd. on multiple projects in the fields of oncology and rare diseases, where the preparation of high-quality HTA reports was crucial for achieving our market access objectives.

The team at HTA Ltd. has demonstrated outstanding expertise, particularly in the development of patient flow analyses and tailored solutions that reflect the complexity of these therapeutic areas. Their collaborative approach, responsiveness and commitment to quality have consistently exceeded our expectations. What we value most in our collaboration is their flexibility with timelines and their openness to feedback, which ensured smooth project execution even under challenging deadlines.

HTA Ltd. consistently provides scientifically rigorous, well-structured, and actionable deliverables that support our strategic decision-making. We highly appreciate their professionalism and recommend them to any pharmaceutical company seeking a reliable and knowledgeable HTA consultancy that truly understands the nuances of the pharmaceutical industry.

Exceed Orphan is company with expertise and track record of successful launches of innovative medications in the field of Rare Diseases in Central & Eastern Europe.

Our collaboration from several years with HTA Ltd. has been focused on projects in the field of rare diseases, where their deep understanding of the complexities of small patient populations and high unmet medical needs has been instrumental in advancing our market access goals.

The HTA Ltd. team has consistently delivered high-quality health technology assessments and pharmacoeconomic analyses, tailored to the unique challenges of orphan therapies. Their work combines scientific precision with strategic insight, ensuring that each submission reflects both the value of innovation and the realities of local healthcare systems. They have been delivering all projects respecting strict deadlines and providing timely expertise based on customer needs.

We highly appreciate HTA Ltd.'s contribution to improving patient access to life-changing rare disease treatments. Their professionalism, flexibility, and commitment to evidence-based decision-making make them a trusted partner for Exceed Orphan in bringing new treatment options to patients with rare diseases.

At Vertex we had a great experience working with HTA Ltd. The experts are very knowledgeable about the Bulgarian healthcare and health economic system. The dossiers they developed were high-quality and with a very good timeline. They took up a last minute dossier request as well which required a lot of extra effort from the team, it's much appreciated.